Lecture 20 - Immunity to Cancer Flashcards

1
Q

What is the elimination phase of cancer surveillance?

A

immune cells (NK, CD4, CD8, etc) recognize tumor cells and kill them before proliferation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the equilibrium phase of cancer surveillance?

A

no true tumor development but mutations arise which decrease immune cell effectiveness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the escape phase of cancer surveillance?

A

Rapid proliferation of tumor cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the 7 steps to the cancer-immunity cycle

A
  1. cancer cell antigen release
  2. antigen presentation
  3. APC/T cell priming and activation
  4. T cell homing to tumors
  5. Infiltration of T cells into tumors
  6. recognition of tumor
  7. killing of cancer cells
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What cell kills tumor cells

A

CD8+ (cytotoxic) T cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the action of perforin?

A

aids in delivering contents of granules into the cytoplasm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the action of granzymes?

A

proteases which activate apoptosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the action of granulysin?

A

antimicrobial that promotes apoptosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the mechanisms by which tumors avoid immune recognition?

A
  • low immunogenicity
  • self antigen
  • antigenic modulation
  • tumor induced immune suppression
  • tumor induced privileged site
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

How does a tumor evade the immune system by:

low immunogenicity

A

no adhesion, co-stimulatory molecules, MHC molecules present

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

How does a tumor evade the immune system by:

self-antigen treatment

A

tumor antigens taken up and presented by APCs tolerize T cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

How does a tumor evade the immune system by:

antigenic modulation

A

tumors will not present immunogenic antigens

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

How does a tumor evade the immune system by:

tumor-induced immune suppression

A

factors secreted by tumor cell inhibit t cells directly (IL-10, TGF-b, PDL-1)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How does a tumor evade the immune system by:

tumor induced privileged sites

A

tumor cells secrete factors that create a cell barrier

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What two steps of the cancer immunity cycle is PDL 1 involved in

A

activation of APC/T cells
killing of cancer cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the 5 types of cancer immunotherapies

A
  1. cell-based immunotherapy
  2. immunomodulators
  3. vaccines
  4. oncolytic viruses
  5. antibody based targeted therapies
17
Q

Explain oncolytic virus immunotherapy

A

inside a healthy cell, virus does not replicate but it does within a cancer cell. when the cancer cell lyses antigens are presented to T cells by DCs - now T cells are “programmed” to kill cancer cells

18
Q

T/F: CAR-T cell therapy is personalized medicine

A

TRUE

19
Q

Explain CAR-T cell therapy

A

T cells are harvested from tumor patient, a retrovirus infects T cells with CD3/CD28, infected cells express anti-CD19, T cells are infused into patient and mediate antitumor activity

20
Q

What do co-inhibitory receptors do

A

regulate uncontrolled activation of lymphocytes through competing with CD28 molecules

21
Q

What are the two immune checkpoints

A

CTLA4 and PD1

22
Q

What is ITIM and what is its job

A

Immunoreceptor Tyrosine-based Inhibitory Motif

recruits phosphatase

23
Q

PDL-1 ____ T cell response

A

inhibits

24
Q

What do blocking of antibodies on PD-1 or PDL-1 prevent

A

inhibition of T cells